JP2025501509A5 - - Google Patents

Info

Publication number
JP2025501509A5
JP2025501509A5 JP2024535921A JP2024535921A JP2025501509A5 JP 2025501509 A5 JP2025501509 A5 JP 2025501509A5 JP 2024535921 A JP2024535921 A JP 2024535921A JP 2024535921 A JP2024535921 A JP 2024535921A JP 2025501509 A5 JP2025501509 A5 JP 2025501509A5
Authority
JP
Japan
Application number
JP2024535921A
Other languages
Japanese (ja)
Other versions
JP2025501509A (ja
JPWO2023114822A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081519 external-priority patent/WO2023114822A1/en
Publication of JP2025501509A publication Critical patent/JP2025501509A/ja
Publication of JP2025501509A5 publication Critical patent/JP2025501509A5/ja
Publication of JPWO2023114822A5 publication Critical patent/JPWO2023114822A5/ja
Pending legal-status Critical Current

Links

JP2024535921A 2021-12-15 2022-12-14 Rxfp1受容体アゴニストとしてのベンゾチアゾール、ベンゾイソオキサゾールおよびベンゾジオキソールアナログ Pending JP2025501509A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289830P 2021-12-15 2021-12-15
US63/289,830 2021-12-15
PCT/US2022/081519 WO2023114822A1 (en) 2021-12-15 2022-12-14 Benzothiazole, benzoisoxazole and benzodioxole analogs as rxfp1 receptor agonists

Publications (3)

Publication Number Publication Date
JP2025501509A JP2025501509A (ja) 2025-01-22
JP2025501509A5 true JP2025501509A5 (https=) 2025-12-18
JPWO2023114822A5 JPWO2023114822A5 (https=) 2025-12-18

Family

ID=85278236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535921A Pending JP2025501509A (ja) 2021-12-15 2022-12-14 Rxfp1受容体アゴニストとしてのベンゾチアゾール、ベンゾイソオキサゾールおよびベンゾジオキソールアナログ

Country Status (6)

Country Link
US (1) US20250066344A1 (https=)
EP (1) EP4448500A1 (https=)
JP (1) JP2025501509A (https=)
KR (1) KR20240120745A (https=)
CN (1) CN118401502A (https=)
WO (1) WO2023114822A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025106780A1 (en) * 2023-11-17 2025-05-22 Eli Lilly And Company Rxfp1 receptor agonists
WO2025235833A1 (en) * 2024-05-10 2025-11-13 Eli Lilly And Company Rxfp1 receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013165606A1 (en) * 2012-05-04 2013-11-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of the relaxin receptor 1
CN106316987B (zh) * 2015-07-03 2020-11-17 江苏恒瑞医药股份有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的应用
WO2019057969A1 (en) * 2017-09-22 2019-03-28 Johann Wolfgang Goethe-Universität DOUBLE AGONISTS OF FXR AND PPARδ, AND USES THEREOF

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
CL2025003360A1 (es) Contactores de fibra de microcanal enzimáticos
BR102023014872A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307046288S (https=)
BY13150U (https=)
CN307044445S (https=)
BY13169U (https=)
CN307045458S (https=)
CN307045507S (https=)
BY13168U (https=)
CN307046565S (https=)
CN307047006S (https=)